In the last week, we've announced two important parts of our continuing plan to keep New Zealanders safe. We have secured access for all New Zealanders to the highly effective Pfizer/BioNTech vaccine, and today we have announced our plan for the vaccine roll-out. Today I want to talk about how these vaccines keep us safe, how we have sequenced our vaccination roll-out plan, and what we can anticipate in the future. The Pfizer/BioNTech vaccine has consistently shown strong results in clinical trials. We knew from the first clinical trial that it offered really strong protection against hospitalisation. This is really important. Look around the countries with large outbreaks and you see hospitals getting overwhelmed. We know that, by access to this vaccine, we can prevent a crisis in our health system. 